LDHA and cancer: Pharmacologic inhibition of ALDH in an epigenetically determined reversibly drug-tolerant subpopulation of cancer cells with CSC characteristics led to the accumulation of ROS to toxic levels specifically in the drug-tolerant subpopulation, suggesting ALDH-mediated protection against oxidative stress in this subpopulation [136].